Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$47.98 - $54.4 $79,982 - $90,684
-1,667 Reduced 2.4%
67,901 $3.68 Billion
Q4 2023

Feb 20, 2024

BUY
$48.48 - $57.85 $3.37 Million - $4.02 Million
69,568 New
69,568 $3.57 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Globalt Investments LLC / Ga Portfolio

Follow Globalt Investments LLC / Ga and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globalt Investments LLC / Ga, based on Form 13F filings with the SEC.

News

Stay updated on Globalt Investments LLC / Ga with notifications on news.